ClinicalTrials.Veeva

Menu

Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning in Patients With Type 1 Diabetes

University of Aarhus logo

University of Aarhus

Status

Completed

Conditions

Diabetes Mellitus, Type 1
Diabetes Complications
Ischemia
Retinal Ischemia

Treatments

Other: Remote Ischemic Conditioning

Study type

Interventional

Funder types

Other

Identifiers

NCT03906383
RIK_RVA Diabetes

Details and patient eligibility

About

Remote ischemic conditioning (RIC) is a therapeutic strategy for protecting organs or tissue against the detrimental effects of acute ischemia-reperfusion injury. It remains unknown whether this can be used in retinal ischemic diseases. The purpose of the present study is to examine if the autoregulation of retinal vessel diameters in diabetic patients change after remote ischemic conditioning and if the observations are different from what have been observed in normal persons.

Enrollment

21 patients

Sex

All

Ages

20 to 31 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diabetes type 1
  • Diabetic retinopathy

Exclusion criteria

  • Previous treatment for diabetic retinopathy
  • Other ocular and systemic diseases requiring treatment
  • Pregnancy or lactation

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

21 participants in 1 patient group

Remote Ischemic Conditioning
Experimental group
Treatment:
Other: Remote Ischemic Conditioning

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems